Botulinum Toxin A in the Treatment of Hemifacial Spasm
Status:
Unknown status
Trial end date:
2018-08-31
Target enrollment:
Participant gender:
Summary
Hemifacial spasm patients who received botulinum toxin A injection were divided into two
groups. Group A received unilateral injection while group B received bilateral injection.
Patients completed follow-up A researcher record facial videos and analyzed facial symmetry
and completed 3 scales.
Phase:
N/A
Details
Lead Sponsor:
Tongji University
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A onabotulinumtoxinA